Product Description
Ref-SKU:
006N-01922 Recombinant HIV-1 plasmid (derived from pNL4-3) with the indicated mutations in the protease gene, which have been reported in the context of clinical drug resistance to HIV protease inhibitors.
Product Risk Group:
Information on the related virus
ICTV Taxonomy:
Virus name:
Subspecies:
Strain:
Isolate:
Genotype:
Cloned Product: Yes
Special feature:
Can it be used to produce GMO:
No
Biosafety restrictions:
Plasmid DNA itself is not infectious unless transfected into suitable cells. Will produce live HIV-1 after transfection into mammalian cells. Infectivity of resulting virus has been verified! The virus has proven drug resistance against clinical HIV protease inhibitors
Region encompassed in this Product:
entire genome of HIV-1
Plasmid:
Plasmid selection:
TAG:
Sequencing:
Fully sequenced
Sequence controlled:
Yes
Mutations:
No mutation compared to the reference sequence
Nucleic Acid preparation technique:
Plasmid-Miniprep (Macherey Nagel)
Storage conditions:
TE Buffer -20C
Shipping conditions:
IATA Classification:
Virus host type:
Information about the origin of the product
Recombinant product:
This product is a recombinant product
Biological material origin:
Synthetic origin & Natural origin
Natural part identification: NL4-3
Natural part identification:
NL4-3
Genbank reference:
Collection date: BEFORE
Monday, 26 July, 2021
Country of collection:
Synthetic part identification: point mutations at the indicated positions
Synthetic part identification:
point mutations at the indicated positions
Genbank reference:
Modifications from the reference sequence(s):
The sequence(s) of this synthetic product has been modified from the sequence listing provided as Genbank references